Diversified science and technology company Danaher (NYSE:DHR) met Wall Streets revenue expectations in Q4 CY2025, with sales ...
Neuberg Sehgal Path Lab, a leading name in diagnostic services, launched a cutting-edge cytogenetics testing technology at ...
Danaher Corporation (NYSE:DHR) Q4 2025 Earnings Call Transcript January 28, 2026 Danaher Corporation beats earnings ...
Neuberg Sehgal PathLab introduces advanced cytogenetics testing for comprehensive cancer diagnosis and prenatal screening: Our Bureau, Mumbai Wednesday, February 4, 2026, 17:30 Hr ...
This technology has vast potential to help patients but remains underutilized and underappreciated. The tools are there. What’s lacking are harmonized controls, regulatory guidelines and database ...
Extracellular vesicles can provide a wealth of information, but these intriguing messengers are notoriously difficult to detect. This could be about to change. Extracellular vesicles (EVs) are a ...
Key opportunities in the Global Esoteric Testing Market include addressing rising chronic disease rates, demand for molecular diagnostics in personalized medicine, and expanding use of liquid biopsy ...
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease marked by irreversible fibrosis and poor prognosis. Growing disease awareness and improved diagnostics are expanding the ...
Learn how to tell if your business could be facing a cash crunch—and what to do about it Written By Written by Staff Senior Editor, Buy Side Miranda Marquit is a staff senior personal finance editor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results